Vanda Pharmaceuticals Inc. 13G filed on 2026-10-09
- Millennium Management LLC owns 4,260,038 shares
- Millennium Group Management LLC owns 4,260,038 shares
- Israel A. Englander owns 4,260,038 shares
MILLENNIUM MANAGEMENT LLC, filed by
VNDA
Vanda Pharmaceuticals Inc. SEC filings
Every EDGAR filing for Vanda Pharmaceuticals Inc. (VNDA), newest first, with AI summaries and stories.
- Ticker
- VNDA
- CIK
- 1347178
- Latest filing
- Oct 9
Next: earnings expected ~Nov 5 · 10-Q expected ~Nov 6 (deadline Nov 9)
Filings
SCHEDULE 13G/AVanda Pharmaceuticals Inc.VNDALIVE SCHEDULE 13GVanda Pharmaceuticals Inc.VNDALIVE Ownership stake disclosure by MILLENNIUM MANAGEMENT LLC
MILLENNIUM MANAGEMENT LLC, filed by
SCHEDULE 13GVanda Pharmaceuticals Inc.VNDALIVE Ownership stake disclosure by AQR CAPITAL MANAGEMENT LLC
AQR CAPITAL MANAGEMENT LLC, filed by
10-QVanda Pharmaceuticals Inc.VNDALIVE 8-KVanda Pharmaceuticals Inc.VNDALIVE 4Vanda Pharmaceuticals Inc.VNDALIVE 8 insider filings
Daniel Patrick McGuire, insider filing for VNDA
Show all 8
- 4Insider filing for VNDA
- 4Insider filing for VNDA
- 4Insider filing for VNDA
- 4Insider filing for VNDA
- 4Insider filing for VNDA
- 4Insider filing for VNDA
- 4Insider filing for VNDA
- 3New insider at VNDA
Daniel Patrick McGuire, reporting
S-8Vanda Pharmaceuticals Inc.VNDALIVE 8-KVanda Pharmaceuticals Inc.VNDALIVE 4Vanda Pharmaceuticals Inc.VNDALIVE Stephen Ray Mitchell, insider filing for VNDA
Stephen Ray Mitchell, reporting
SCHEDULE 13GVanda Pharmaceuticals Inc.VNDALIVE Ownership stake disclosure by STATE STREET CORP
STATE STREET CORP, filed by
10-QVanda Pharmaceuticals Inc.VNDALIVE 8-KVanda Pharmaceuticals Inc.VNDALIVE EFFECTVanda Pharmaceuticals Inc.VNDALIVE SCHEDULE 13G/AVanda Pharmaceuticals Inc.VNDALIVE Ownership stake disclosure by BlackRock Portfolio Management LLC (amended)
BlackRock Portfolio Management LLC, filed by
4Vanda Pharmaceuticals Inc.VNDALIVE 2 insider filings
Charles Cliff Duncan, insider filing for VNDA
Show all 2
- 4Insider filing for VNDA
- 3New insider at VNDA
Charles Cliff Duncan, reporting
ARSVanda Pharmaceuticals Inc.VNDALIVE DEFA14AVanda Pharmaceuticals Inc.VNDALIVE DEF 14AVanda Pharmaceuticals Inc.VNDALIVE 8-KVanda Pharmaceuticals Inc.VNDALIVE 3Vanda Pharmaceuticals Inc.VNDALIVE 2 insider filings
Christos Vasilios Mihael Polymeropoulos, new insider at VNDA
Show all 2
- 3New insider at VNDA
- 3New insider at VNDA
Christos Vasilios Mihael Polymeropoulos, reporting
8-KVanda Pharmaceuticals Inc.VNDALIVE SCHEDULE 13G/AVanda Pharmaceuticals Inc.VNDALIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
8-KVanda Pharmaceuticals Inc.VNDALIVE 4Vanda Pharmaceuticals Inc.VNDALIVE 5 insider filings
Timothy Williams, insider filing for VNDA
Show all 5
- 4Insider filing for VNDA
- 4Insider filing for VNDA
- 4Insider filing for VNDA
- 4Insider filing for VNDA
- 4Insider filing for VNDA
Timothy Williams, reporting
144Vanda Pharmaceuticals Inc.VNDALIVE 5 Form 144 notices
Timothy Williams, planned sale of VNDA shares
Show all 5
- 144Planned insider sale of VNDA shares
- 144Planned insider sale of VNDA shares
- 144Planned insider sale of VNDA shares
- 144Planned insider sale of VNDA shares
- 144Planned insider sale of VNDA shares
Timothy Williams, reporting
4Vanda Pharmaceuticals Inc.VNDALIVE Tage Honore, insider filing for VNDA
Tage Honore, reporting
144Vanda Pharmaceuticals Inc.VNDALIVE Tage Honore, planned sale of VNDA shares
Tage Honore, reporting
8-KVanda Pharmaceuticals Inc.VNDALIVE 4Vanda Pharmaceuticals Inc.VNDALIVE 5 insider filings
Joakim Wijkstrom, insider filing for VNDA
Show all 5
- 4Insider filing for VNDA
- 4Insider filing for VNDA
- 4Insider filing for VNDA
- 4Insider filing for VNDA
- 4Insider filing for VNDA
Joakim Wijkstrom, reporting